The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...
Phase 3 of the Centers for Medicare & Medicaid Services’ Requirements for Participation for nursing facilities will go into effect on November 28. But those who have not yet read CMS’s recent ...